Status:
COMPLETED
Probiotics for Birch Pollen Allergy
Lead Sponsor:
Danisco
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
2-10 years
Phase:
PHASE1
PHASE2
Brief Summary
Birch pollen allergy is one of the most common forms of respiratory allergy in the Nordic countries. Treatment consists of antihistamine use. Specific probiotic strains have been observed to modulate ...
Eligibility Criteria
Inclusion
- Physician verified birch pollen allergy
Exclusion
- Diagnosed asthma Habitual use of probiotics and/or prebiotics
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00746226
Start Date
March 1 2006
End Date
February 1 2007
Last Update
September 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Central Hospital
Turku, Finland, 20250